May/June 2026

Anti-VEGF Step Therapy: An Update

Despite ongoing advocacy efforts, this payer policy persists, putting vision at risk.

Lucas McGuire, BS; Baseer Ahmad, MD; and Jennifer Adeghate, MD, PhD

Angiogenesis 2026: Highlights

New data on wet and dry AMD therapies, AI, and more.

Alex Brodin, MA, Senior Editor, and Rebecca Hepp, MA, Editor-in-Chief

Landmark Trials in AMD

A summary of the clinical trials that have shaped—and continue to shape—how we treat AMD.

Saghar Bagheri, MD, PHD; Alberto Quarta, MD; Rouzbeh Abbasgholizadeh, MD; Alessandro Feo, MD; Paolo Forte, MD; David Sarraf, MD; Michael S. Ip, MD; and SriniVas R. Sadda, MD, FARVO

Starting Retina Fellowship: Four Strategies for Success

Make the most of this pivotal time in your retina career.

Justin C. Muste, MD, and David Fell, MD

Drug Interactions in Immunosuppressive Therapy for Uveitis

A review of the toxic relationships to avoid when managing patients with uveitis.

Ioannis Papasavvas, MD, and Carl P. Herbort, Jr, MD, PD

Ophthalmic Oncology Perspectives at ARDS

During the 54th annual meeting, Tara A. McCannel, MD, PhD, explored the utility of prognostic biopsy and the psychological ups and downs that come with a cancer diagnosis.

James Winebrake, MD

Pearls and Pitfalls of Treating GA and Wet AMD

Concurrent therapy can pose clinical challenges. Here’s how you can manage these patients and maximize outcomes.

Sean D. Adrean, MD, FAAO, and Wesley Han, BS

Novel MOAs in Wet AMD

The pipeline is full of therapies that hold promise for extending treatment efficacy.

Lejla Vajzovic, MD, FASRS; Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi

Choroidal Nevus Growth Into Melanoma in a Young Patient

Know the clinical risk factors for the development of malignancy.

Henry M. Nguyen, BS; Aruba Zafar, MD; Robert J. Medina, BA; and Carol L. Shields, MD

The AMD Space Race

Allen C. Ho, MD; Robert L. Avery, MD; and Lejla Vajzovic, MD

PBM for AMD: Mechanisms, Evidence, and Clinical Integration

Photobiomodulation shows promise, but long-term data are needed.

Luis Acabá-Berrocal, MD, and Anton Orlin, MD

Predicting Progression to GA Using Imaging Biomarkers

Several OCT findings can help clinicians better understand a patient’s risk of progression to sight-threatening disease.

Kelly Donovan, MD, PhD, and Eleonora M. Lad, MD, PhD

Influence of Mediterranean-Style Diet on AMD

Our findings suggest certain dietary and lifestyle habits may confer long-term protective benefits.

Christopher Phung, BA; Beryl Zhou, BS; Robert Luca, BA; and Dimitra Skondra, MD, PhD

A Primer on FAF

Even with the advances in imaging technology, fundus autofluorescence remains integral to our imaging protocols. Here’s why.

Thomas Ach, MD, MSc, FEBO, and Andreas Pollreisz, MD

Retina Then and Now: May/June Spotlight

As part of our 20th anniversary, Retina Today is digging into the archives to reflect on how much the profession has changed.

Michael S. Ip, MD

Peripheral Firestorm: The Ischemic Retina

Proliferative disease may still be progressing despite good vision.

Apoorva Jadhav, MBBS, DNB; Unnikrishnan Nair, MS, FRCS, FMRF; and Manoj Soman, DNB, FICO, FRCS

Fibrin Glue in Retina Surgery

This tried-and-true tool may be a valuable tamponade alternative.

Lawrence Chan, MD; Tanner Frediani, MD; and Gaurav K. Shah, MD